- Fellowship, State University of New York (SUNY), 2001–2004
- Residency, Wayne State University Program, 1998–2001
- Ph.D., Wayne State University, 1999
- M.D., Bangalore Medical College, 1991
Our ultimate goal is to develop effective therapies that simultaneously target metabolic and vascular dysfunction in obesity and diabetes.
Our research focuses on studies of the metabolic and vascular actions of insulin and how these actions are impaired in insulin-resistant states such as obesity, diabetes, and cardiovascular disease. Insulin-mediated microvascular recruitment plays an important role in glucose disposal and is frequently impaired in people with obesity and diabetes. We perform clinical studies that seek to understand how therapeutic interventions modulate biological actions of insulin and the molecular mechanisms of insulin resistance that play a role in coupling metabolic and vascular dysfunction in obesity and diabetes. Our research is also directed toward understanding the physiologic basis for the higher prevalence of cardiovascular dysfunction and insulin resistance in ethnic minorities such as African-Americans, Hispanic/Latinos, and Asians.
Applying our Research
Cardiovascular disease is a major cause of mortality and morbidity in diabetes. Developing novel therapies that target cardiovascular risk in obesity and diabetes will greatly benefit our patients with diabetes and obesity.
- A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline for the Management of Hyperglycemia in Adults Hospitalized for Noncritical Illness or Undergoing Elective Surgical Procedures.
- Seisa MO, Saadi S, Nayfeh T, Muthusamy K, Shah SH, Firwana M, Hasan B, Jawaid T, Abd-Rabu R, Korytkowski MT, Muniyappa R, Antinori-Lent K, Donihi AC, Drincic AT, Luger A, Torres Roldan VD, Urtecho M, Wang Z, Murad MH.
- J Clin Endocrinol Metab (2022 Jul 14) 107:2139-2147. Abstract/Full Text
- Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline.
- Korytkowski MT, Muniyappa R, Antinori-Lent K, Donihi AC, Drincic AT, Hirsch IB, Luger A, McDonnell ME, Murad MH, Nielsen C, Pegg C, Rushakoff RJ, Santesso N, Umpierrez GE.
- J Clin Endocrinol Metab (2022 Jul 14) 107:2101-2128. Abstract/Full Text
Research in Plain Language
We study how some diseases interfere with the ability of insulin to break down sugar in the body andthe ways that treating these diseases influences the effects of insulin. Our team also conducts research to help understand why some ethnic minorities are more likely than other groups to have cardiovascular problems and lower insulin efficiency.